Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III multicenter randomized trial of perioperative triplet versus doublet chemotherapy for advanced gastric cancer
ChiCTR-TRC-14004983Phase 3Recruiting
- Sponsor
- The Fourth Hospital of Hebei Medical University
- Start
- Jul 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of docetaxel, oxaliplatin and capecitabine in gastric adenocarcinoma and gastric cancer (GC) (3 arms), sponsored by The Fourth Hospital of Hebei Medical University. Primary endpoint: Pathological complete response rate. Started Jul 2014; status: recruiting.
02
Drugs
docetaxeloxaliplatincapecitabine
03
Conditions
gastric adenocarcinomagastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR-TRC-14004983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004983.